Abstract CT125: STRO-002-GM1, a First in Human, Phase 1 Study of STRO-002, an Anti-Folate Receptor Alpha (frα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum-Resistant/refractory Epithelial Ovarian Cancer (OC), Including Fallopian Tube or Primary Peritoneal Cancers
Cancer Research(2020)
Key words
Monoclonal Antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined